Atrial fibrillation with rapid ventricular response (AFib with RVR) is treated by slowing the heart rate below 110 beats per minute, either with intravenous medications in an emergency setting or with oral medications for ongoing management. RVR means the heart’s lower chambers are beating too fast, generally above 110 BPM, because the chaotic electrical signals from the upper chambers are passing through unchecked. Treatment depends on how stable you are, what’s driving the fast rate, and whether the goal is to control heart rate, restore normal rhythm, or both.
What Makes RVR Different From Regular AFib
In all atrial fibrillation, the heart’s upper chambers quiver instead of contracting in a coordinated way. Many people live with AFib at a manageable heart rate and feel relatively fine. RVR is the label applied when those chaotic signals push the ventricles (the main pumping chambers) above 110 BPM at rest. At that speed, the heart doesn’t fill properly between beats, which reduces blood flow to the brain and body. That’s why RVR often causes noticeable symptoms: pounding or racing heartbeat, dizziness, shortness of breath, chest pressure, and sometimes fainting.
RVR can be the first sign of new AFib, or it can be a flare in someone with known AFib whose rate was previously controlled. Either way, it typically needs prompt treatment because a sustained fast rate strains the heart muscle over time and can lead to heart failure if left unchecked.
Immediate Treatment in the Hospital
When you arrive at an emergency department with AFib and RVR, the first thing the medical team assesses is hemodynamic stability: whether your blood pressure, consciousness, and organ function are holding up. That distinction determines the entire treatment path.
If You’re Stable
Most people with AFib and RVR are uncomfortable but stable. The standard approach is an IV medication to slow the heart rate. Calcium channel blockers (most commonly diltiazem) and beta-blockers (most commonly metoprolol) are the first-line options. Diltiazem is given as an IV push based on body weight, with a second dose if the heart rate stays above 100. If it works, a continuous IV drip keeps the rate controlled while the care team figures out next steps. Metoprolol is given as a small IV bolus, repeated up to three times if needed.
Which drug you receive depends on your other health conditions. Beta-blockers are often preferred if you have heart failure or coronary artery disease. Calcium channel blockers may be chosen if you have lung disease that makes beta-blockers risky. Both drugs typically bring the heart rate down within minutes.
If You’re Unstable
When RVR causes dangerously low blood pressure, altered consciousness, severe chest pain, or signs of shock, there isn’t time to wait for medications to take effect. The treatment is synchronized electrical cardioversion, a controlled shock delivered to the chest that resets the heart’s rhythm. The initial energy recommended for AFib is 100 to 200 joules. You’re sedated briefly for this procedure, and it works within seconds. It doesn’t always hold (the AFib may return), but it buys time and restores blood flow.
Finding and Fixing the Trigger
A fast ventricular rate in AFib rarely happens in a vacuum. Something usually pushes the rate up, and treating the underlying cause is just as important as slowing the heart. Common triggers include infection or sepsis, dehydration, overactive thyroid (hyperthyroidism or thyroid storm), alcohol use, recent surgery, uncontrolled pain, pulmonary embolism, and acute heart failure.
If you’re being treated for AFib with RVR and your heart rate isn’t responding well to the usual medications, the medical team will look hard for a secondary cause. An infection driving a fever, for example, keeps the heart rate elevated no matter how much rate-control medication you receive. Thyroid storm is a particularly dangerous trigger that requires its own specific treatment before the heart rate will stabilize. Fixing the underlying problem often resolves the RVR entirely, especially in people who don’t have a history of AFib.
A Critical Safety Exception: WPW Syndrome
One scenario changes the treatment rules completely. In Wolff-Parkinson-White (WPW) syndrome, there’s an extra electrical pathway between the upper and lower chambers. If AFib occurs in someone with WPW, the standard rate-control drugs, including beta-blockers, diltiazem, verapamil, digoxin, and amiodarone, are all contraindicated. These medications can paradoxically funnel more electrical impulses through the abnormal pathway and trigger a life-threatening rhythm. WPW is identified on an EKG by a characteristic pattern, and the treatment team will use a different approach, often proceeding straight to cardioversion.
Rate Control vs. Rhythm Control
Once the acute crisis is managed, a decision needs to be made about the long-term strategy. Rate control means accepting that AFib will continue but keeping the ventricular rate at a safe speed with daily medication. Rhythm control means actively trying to restore and maintain a normal sinus rhythm, using medications, electrical cardioversion, or catheter ablation.
For rate control, the target heart rate is more flexible than many people expect. A landmark trial published in the New England Journal of Medicine compared a strict strategy (resting heart rate below 80 BPM) with a lenient strategy (resting heart rate below 110 BPM) in 614 patients with permanent AFib. Both strategies produced similar outcomes, meaning a resting rate under 110 is a reasonable and often sufficient goal. The lenient target is easier to achieve with lower medication doses and fewer side effects.
The 2023 ACC/AHA guidelines have increasingly emphasized early rhythm control, particularly for people diagnosed with AFib within the past year. Newer evidence suggests that restoring normal rhythm early, rather than settling for rate control alone, may reduce the risk of stroke, heart failure, and cardiovascular death. This is a shift from older thinking that treated rate and rhythm control as roughly equivalent strategies.
Long-Term Medications
After leaving the hospital, most people with AFib and a history of RVR take at least two types of medication: one for rate or rhythm control and one to prevent blood clots.
For rate control, oral versions of the same drug classes used in the ER are standard. Beta-blockers and calcium channel blockers are the backbone, taken daily. Digoxin is sometimes added as a second agent if a single drug isn’t enough, though it’s rarely used alone.
For rhythm control, antiarrhythmic medications can help maintain normal sinus rhythm after cardioversion. Catheter ablation is another option, a procedure where a specialist threads a catheter into the heart and destroys the small areas of tissue generating the abnormal electrical signals. Current guidelines recommend ablation as a reasonable choice for many patients, and it has become increasingly common as both the technology and outcomes have improved. Some people need more than one ablation procedure, as AFib can recur, but many achieve long-term rhythm control.
Stroke Prevention With Blood Thinners
AFib increases stroke risk because blood can pool and clot in the quivering upper chambers. This risk exists whether your rate is fast or controlled, so stroke prevention is a separate and essential part of treatment. Doctors use a scoring system called CHA2DS2-VASc to estimate your individual stroke risk based on factors like age, sex, history of heart failure, high blood pressure, diabetes, prior stroke, and vascular disease.
A score of 2 or higher is a clear indication for oral anticoagulation (blood thinners). A score of 1 places you in an intermediate-risk category where anticoagulation is generally preferred over aspirin. A score of 0 means the stroke risk is low enough that blood thinners may not be needed. Most people hospitalized for AFib with RVR will have at least one risk factor, so the majority leave the hospital on an anticoagulant.
What Recovery Looks Like
If your RVR episode was triggered by something reversible, like an infection or thyroid problem, you may not need long-term AFib treatment at all once the trigger is resolved. Your doctor will likely monitor you with follow-up EKGs or a wearable heart monitor to see if AFib returns.
If AFib is a chronic condition for you, the goal after an RVR episode is preventing the next one. That means optimizing your daily medications, managing contributing conditions like high blood pressure, sleep apnea, obesity, and heavy alcohol use, and knowing your personal warning signs. Many people with well-managed AFib go years without another RVR episode. The key is consistent medication use, regular follow-up, and addressing the lifestyle factors that make AFib harder to control.